Attached files

file filename
EX-4.5 - AMENDMENT TO NON-NEGOTIABLE PROMISSORY NOTE - ID Perfumes, Inc.aena_ex45.htm
EX-32.2 - CERTIFICATION - ID Perfumes, Inc.aena_ex322.htm
EX-32.1 - CERTIFICATION - ID Perfumes, Inc.aena_ex321.htm
EX-31.1 - CERTIFICATION - ID Perfumes, Inc.aena_ex311.htm
EX-31.2 - CERTIFICATION - ID Perfumes, Inc.aena_ex312.htm
EXCEL - IDEA: XBRL DOCUMENT - ID Perfumes, Inc.Financial_Report.xls


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549

Form 10-Q

(Mark One)
 
þ Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2013.
 
o Transition Report under Section 13 or 15(d) of the Exchange Act For the transition period from ________ to ___________.
 
ID PERFUMES, INC.
(Exact Name of Registrant as Specified in its Charter)

Nevada
 
000-52675
 
20-8837626
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

1250 East Hallandale Beach Blvd. Suite 402
Hallandale, Florida 33009
(Address of principal executive offices)

Phone: 954-454-9978
(Registrant's telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes  þ No  ¨.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  þ No  ¨.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer”, “large accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer    ¨
Accelerated filer    ¨
Non-accelerated filer    ¨
Smaller reporting company    þ
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2) of the Act. Yes  ¨ No  þ.
 
State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date:

As of November 18, 2013 the registrant's outstanding common stock consisted of 4,115,837 shares, $0.001 par value.
 


 
 
 
 
 
ID PERFUMES, INC.

TABLE OF CONTENTS
 
     
Page
 
PART I - FINANCIAL INFORMATION
         
Item 1.
Financial Statements
     
 
Condensed Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012
   
3
 
 
Condensed Statements of Operations for the Three and Nine months ended September 30, 2013 and 2012 (unaudited)
   
4
 
 
Condensed Statements of Shareholders’ Deficiency for the Year Ended December 31, 2012 and Nine Months Ended September 30, 2013 (unaudited)
   
5
 
 
Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2013 and 2012 (unaudited)
   
6
 
 
Notes to Condensed Financial Statements (unaudited)
   
7
 
Item 2.
Management’s Discussion and Analysis or Plan of Operation
   
25
 
Item 3.
Quantitative and Qualitative Disclosure About Market Risk
   
33
 
Item 4.
Controls and Procedures
   
33
 
           
PART II - OTHER INFORMATION
           
Item 1.
Legal Proceedings
   
34
 
Item 1A.
Risk Factors
   
34
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
   
35
 
Item 3.
Defaults Upon Senior Securities
   
35
 
Item 4.
Mine Safety Disclosures
   
35
 
Item 5.
Other Information
   
35
 
Item 6.
Exhibits
   
35
 
           
SIGNATURES
   
36
 

 
 
2

 
 
PART I. FINANCIAL INFORMATION
 
ITEM 1.  FINANCIAL STATEMENTS
ID PERFUMES, INC.
Condensed Balance Sheets
 
   
September 30,
   
December 31,
 
   
2013
   
2012
 
   
(Unaudited)
       
Assets
           
Current Assets:
           
Cash and cash equivalents
 
$
3,485
   
$
316,138
 
Accounts receivable
   
178,982
     
-
 
Inventory
   
2,390,543
     
671,709
 
Prepaid royalties
   
-
     
166,667
 
Prepaid expenses and other current assets
   
18,118
     
51,784
 
Deposits
   
-
     
64,822
 
Total Current Assets
   
2,591,128
     
1,271,120
 
                 
Equipment, net
   
197,389
     
220,058
 
Deposits
   
46,377
     
46,377
 
     
243,766
     
266,435
 
                 
Total Assets
 
$
2,834,894
   
$
1,537,555
 
                 
Liabilities and Shareholders’ Deficiency
               
                 
Current Liabilities:
               
Accounts payable
 
$
4,217,524
   
$
1,496,272
 
Accrued liabilities
   
4,542,000
     
4,215,345
 
Loans payable
   
463,076
     
230,000
 
Note payable, related party
   
560,000
     
-
 
Debenture payable and related derivative liability
   
556,530
     
-
 
Current portion of related party and stockholder notes
   
99,930
     
2,613,936
 
Accrued interest payable to related party and stockholder notes
   
1,025,729
     
938,544
 
Short term liabilities – related party
   
548,826
     
-
 
Due to affiliate
   
100,919
     
1,048,488
 
Customer deposits
   
872,935
     
599,034
 
Customer deposits – related parties
   
711,727
     
1,241,449
 
Total Current Liabilities
   
13,699,196
     
12,383,068
 
                 
Long Term Liabilities:
               
Note payable
   
900,000
     
-
 
Long term portion of related party and stockholder notes
   
2,650,408
     
-
 
Total Long Term Liabilities
   
3,550,408
     
-
 
                 
Total Liabilities
   
17,249,604
     
12,383,068
 
                 
Commitments and contingencies
               
                 
Shareholders’ Deficiency
               
Common stock, $0.001 par value per share; authorized 10,000,000 shares, issued and outstanding 4,115,837 and 4,100,837 at September 30, 2013 and December 31, 2012, respectively
   
4,115
     
4,100
 
Preferred stock, $0.001 par value per share; authorized 5,000,000 shares, -0-issued and outstanding at September 30, 2013 and December 31, 2012, respectively
               
Additional paid-in capital
   
24,461,552
     
24,301,567
 
Accumulated deficit
   
(38,880,377
)
   
(35,151,180
)
                 
Total Shareholders’ Deficiency
   
(14,414,710
)
   
(10,845,513
)
                 
Total Liabilities and Shareholders’ Deficiency
 
$
2,834,894
   
$
1,537,555
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.

 
3

 
 
ID PERFUMES, INC.
Condensed Statements of Operations
 (Unaudited)
 
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2013
   
2012
   
2013
   
2012
 
                         
Sales
                       
Sales
  $ 1,832,103     $ 2,727,734     $ 5,498,316     $ 3,618,727  
Sales - related parties
    135,998       72,056       540,167       573,769  
      1,968,101       2,799,790       6,038,483       4,192,496  
Cost of sales
    1,325,772       1,643,667       3,135,968       2,428,521  
Gross Profit
    642,329       1,156,123       2,902,515       1,763,975  
Selling, general and administrative expenses
    1,657,470       2,184,687       6,489,312       4,109,763  
Operating loss
    (1,015,141 )     (1,028,564 )     (3,586,797 )     (2,345,788 )
                                 
Other income / (expense)
                               
Interest expense
    (70,351 )     (92,842 )     (191,759       (231,332 )
Gain on disposition of license
    65,454       -       65,454       -  
Other
    (5,288 )     -       (16,095 )     -  
      (10,185 )     (92,842 )     (142,400 )     (231,332 )
                                 
Loss from continuing operations
    (1,025,326 )     (1,121,406 )     (3,729,197 )     (2,577,120 )
                                 
Discontinued operations:
                               
Net loss
    -       (126,370 )     -       (507,478 )
Gain on disposal – related party
            63,223               63,223  
Loss from discontinued operations
    -       (63,147 )     -       (444,255 )
                                 
Net loss
  $ (1,025,326 )   $ (1,184,553     $ (3,729,197 )   $ (3,021,375 )
                                 
                                 
Continuing operations
    (0.25 )     (0.35 )     (0.91 )     (0.82 )
Discontinued operations
    -       (0.02 )     -       (0.14 )
Net income (loss) per share
  $ (0.25 )   $ (0.37 )   $ (0.91 )     (0.96 )
                                 
Weighted average number of common shares outstanding, Basic and Diluted
    4,115,837       3,125,837       4,112,247       3,125,837  

The accompanying notes are an integral part of these unaudited condensed financial statements.

 
4

 
 
ID PERFUMES, INC.
Condensed Statements of Stockholders' Deficiency
For the Year Ended December 31, 2012 and the Nine Months Ended September 30, 2013
 
   
Common
Shares
   
Common
Shares
   
Additional
Paid In
Capital
   
Accumulated
Deficit
   
Total
Deficiency
 
Balance at January 1, 2012
    3,125,837     $ 3,125     $ 23,223,542     $ (30,896,244 )   $ (7,669,577 )
                                         
Issuance of common stock for cash
    15,000       15       64,985       -       65,000  
                                         
Issuance of common stock for conversion of related party debt
    960,000       960       959,040       -       960,000  
                                         
Share-based compensation
    -       -       54,000       -       54,000  
                                         
Net loss
    -       -       -       (4,254,936 )     (4,254,936 )
                                         
Balance at December 31, 2012
    4,100,837     $ 4,100     $ 24,301,567     $ (35,151,180 )   $ (10,845,513 )
                                         
Issuance of common stock for cash
    15,000       15       59,985       -       60,000  
                                         
Issuance of warrants
                    100,000               100,000  
                                         
Net loss
    -       -       -       (3,729,197 )     (3,729,197 )
                                         
Balance at September 30, 2013 (unaudited)
    4,115,837     $ 4,115     $ 24,461,552     $ (38,880,377 )   $ (14,414,710 )

The accompanying notes are an integral part of these unaudited condensed financial statements.

 
5

 
ID PERFUMES, INC.
Condensed Statements of Cash Flows
For the Nine Months Ended September 30,
(Unaudited)
 
   
2013
   
2012
 
             
Cash from Operating Activities:
           
Net loss
 
$
(3,729,197
)
 
$
(3,021,375
)
Adjustments to reconcile net loss to net cash
               
used in operating activities:
               
Depreciation
   
88,764
     
3,787
 
Amortization
   
166,667
     
208,333
 
Share based compensation
   
-
     
54,000
 
Issuance of warrants
   
100,000
     
-
 
Gain on disposal – related party
   
-
     
(63,223
)
Change in fair value of derivative liability
   
56,530
     
-
 
Changes in assets and liabilities:
               
Accounts receivable
   
(178,982
)
   
(373,071
)
Inventory
   
(1,718,834
)
   
(189,717
)
Prepaid expenses and other assets
   
33,666
     
40,225
 
Deposits
   
64,822
     
(46,377
)
Assets held for sale
   
-
     
(8,953
)
Accounts payable
   
2,721,252
     
715,473
 
Accrued liabilities
   
326,654
     
1,789,353
 
Accrued interest payable to related party and shareholder notes
   
87,185
     
152,359
 
Customer deposits
   
(255,821)
     
358,200
 
Liabilities held for sale
   
-
     
88,021
 
                 
Total Adjustments
   
1,491,903
     
2,728,410
 
                 
Net Cash Used in Operating Activities
   
(2,237,294
)
   
(292,965
)
                 
Cash Flows from Investing Activities:
               
Purchase of property and equipment, net
   
(153,900
)
   
(66,473
Disposal of property and equipment, net
   
87,805
     
-
 
                 
Net Cash Used in Investing Activities
   
(66,095
)
   
(66,473
                 
Cash Flows from Financing Activities:
               
Proceeds from related party and stockholder notes
   
540,000
     
-
 
Repayment of related party and stockholder notes
   
(403,598
)
   
(536,414
)
Proceeds from notes payable
   
333,076
     
-
 
Repayment of notes payable
   
(100,000
)
       
Proceeds from notes payable, related party
   
560,000
     
-
 
Proceeds from debenture payable
   
500,000
     
-
 
Proceeds from affiliate borrowings
   
-
     
912,704
 
Repayment of due to affiliate
   
(47,569
)
   
-
 
Borrowings from Factor
   
12,457
     
2,303,117
 
Repayments to Factor
   
(12,457
)
   
(2,303,117
)
Proceeds from short term borrowings – related party
   
1,594,603
     
-
 
Repayment of short term borrowings – related party
   
(1,045,776
)
   
-
 
Proceeds from issuance of common stock
   
60,000
     
-
 
                 
Net Cash Provided by Financing Activities
   
1,990,736
     
376,290
 
                 
Net (Decrease) Increase in Cash and Cash Equivalents
   
(312,653
)
   
16,852
 
                 
Cash and Cash Equivalents – January 1
   
316,138
     
7,988
 
                 
Cash and Cash Equivalents – September 30
 
 $
3,485
   
$
24,840
 
                 
Supplemental Disclosures of Cash Flow Information:
               
Cash paid for interest
 
$
38,606
   
$
78,969
 
                 
Supplemental Disclosures of Non-Cash Information:
               
Assumption of guaranteed related party debt   $ 900,000       -  
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
 
6

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

Note 1 Description of Business, Basis of Presentation and Summary of Significant Accounting Policies
 
Description of Business and Basis of Presentation

Interim Financial Statements

These statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the financial statements included in the Company’s Registration Statement on Form 10 for the year ended December 31, 2012.

The Company and its Significant Accounting Policies

Business of the Company

ID Perfumes, Inc. (the “Company”) is in the fragrance business, and manufactures and distributes fragrances and fragrance related products. On February 7, 2013, an amendment to the Company’s Articles of Incorporation was signed to change the Company’s name from Adrenalina, Incorporated to ID Perfumes, Inc. The name change more accurately reflects the Company’s ongoing fragrance operations. Through 2008, the Company primarily focused on its’ retail operations while maintaining a small portion of its media and entertainment operations. The retail operations included the sale of active beach and rugged sportswear. In 2009, the Company discontinued its media and entertainment operations to focus on retail operations. On September 30, 2011, the Company formally decided to discontinue its retail store operations that sold active sportswear, and to close, abandon, dispose or sell its assets relating to its retail operations. The Company decided to dispose of its retail stores because it incurred significant operating losses and was unable to sustain a viable business model for the past six years.

All of our prestige fragrance brands are licensed from unaffiliated third parties and our business is dependent upon the continuation and renewal of such licenses. Revenues generated from one such license represented 41% and 65% of our net sales for the quarter and nine months ended September 30, 2013 and from another license represented 81% and 79% or our net sales for the quarter and nine months ended September 30, 2012 No such sales were in the first three quarters of 2012.

Use of Estimates

Management Estimates
 
Management makes assumptions and estimates to prepare financial statements in conformity with accounting principles generally accepted in the United States of America. Those assumptions and estimates directly affect the amounts reported and disclosures included in the financial statements. Actual results could differ from those assumptions and estimates. Significant estimates for which changes in the near term are considered reasonably possible and that may have a material impact on the financial statements are disclosed in these notes to the financial statements.

Cash and Cash Equivalents
 
The Company considers all highly liquid accounts with an original maturity date of three months or less to be cash equivalents. The Company maintains bank accounts in US banks, which at times, may exceed federally insured limits.

 
7

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
Accounts Receivable
 
Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for sales returns, cooperative advertising and doubtful accounts or balances which are estimated to be uncollectible. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns.

In June 2012 the Company entered into a factoring arrangement whereby the Factor agreed to purchase without recourse up to $2 million of the face value of approved retailers’ valid accounts receivable, subject to a 35% reserve. The Company removes such receivables from its financial statements upon sale. Interest is based on the “Prime Rate”. The agreement was for 6 months with renewal provisions. For the nine months ended September 30, 2013 and 2012, the Company had borrowed and repaid an aggregate of $12,457 and $2,303,117 respectively, and this amount is reflected in Financing Activities in the statement of cash flows. At September 30, 2013, and December 31, 2012, no amounts were due to the Factor.  The agreement was terminated May 8, 2013.

Inventory
 
Inventory consists of raw materials and finished goods and is stated at the lower of cost or market with cost being determined on the average cost method. The cost of inventory includes product cost and freight charges. Write-offs of potentially slow moving or damaged inventory are recorded based on management’s analysis of inventory levels, future sales forecasts and through specific identification of obsolete or damaged merchandise.

Inventory, including promotional merchandise, only include inventory considered saleable or usable in future periods. Cost components include raw materials and components.

Equipment
 
Equipment is stated at cost less accumulated depreciation. At September 30, 2013, equipment represents molds used in the production of perfume components. Depreciation is provided using the straight-line method over the estimated useful lives for equipment of three years.
 
Derivative Instruments

The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification and paragraph 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the Statement of Operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. This requires the Company to reliably measure the embedded derivatives. If the Company cannot reliably measure the embedded derivatives, they will elect under ASC 815-15-30 not to separate the derivative and to value the Hybrid Financial Instrument at fair value in total.
 
In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
 
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.
 
Customer Deposits

The Company receives customer deposits in advance of future sales. The deposits are primarily from international clients and distributors. The deposits are recorded as a liability until the sale occurs. At the time of shipment, the deposits are recorded as revenue.

Concentration
 
The Company is a manufacturer, marketer and distributor of fragrance and fragrance related products, and sells its products to department stores, perfumeries, specialty retailers, mass-market retailers, and domestic and international wholesalers and distributors. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk.
 
 
8

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
Three customers accounted for 87% of net sales for the third quarter of 2013 and 63% of net sales for the first nine months of 2013. The Company is dependent upon a limited number of suppliers for its primary components and manufacturing process.
 
Purchases from four vendors aggregated 96% of total purchases for the three months ended September 30, 2013 and purchases from three vendors aggregated 73% of total purchases for the nine months ended September 30, 2013.  In addition, another vendor provided 100% of a raw material component in both periods.
 
Revenue Recognition
 
Our revenues are derived principally from direct sales to retailers and wholesalers. Our standard arrangement for our customers includes a valid purchase order or contract. We recognize revenues from sale of products when:
 
We enter into a legally binding arrangement with a customer;

Products are shipped and the customer takes title and assumes risk of loss;

Customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and

Collection is reasonably assured.
 
Sales are reported on a net sales basis, which is computed by deducting from gross sales a reserve for product returns, which includes actual returns to date and an amount established for anticipated product returns, as well as trade allowances. Our practice is to accept product returns from retailers only if properly requested, authorized and approved. In accepting returns, we typically provide a credit to the retailer against accounts receivable from that retailer.
 
Allowances for estimated returns are provided for when the related sales are recorded. We continually review and revise our sales returns estimates based on actual product returns and recoverability, planned product discontinuances and promotional sales. In the past, returns provisions have been adjusted higher or lower during the course of fiscal year depending on actual results to date and anticipated returns for the remainder of the year. Experience has shown a relationship between gross sales and sales returns in the subsequent period, as well as a consistent pattern of returns due to the seasonal nature of our business. In addition, as necessary, specific accruals may be established for known anticipated events that we have considered and will continue to consider, including the solvency of our customers, store closings by retailers, changes in the retail environment and decisions regarding new and existing products.
 
We offer trade allowances and other sales incentives to customers in the normal course of business. We also have arrangements with customers pursuant to our trade terms to reimburse them for a portion of their advertising costs which provide advertising benefits to us or incentivize our retail customers or the end consumer. These arrangements include mark down allowance, cooperative advertising spending, retail marketing and miscellaneous allowances (collectively, “trade allowances”). Trade allowances are provided for based on estimates, including anticipated deductions to be taken by our customers for the trade allowance programs provided to them, and historical experience. Trade allowances cost, if any, are recorded as incurred as an offset against sales in our condensed statements of operation. Other sales incentives are recorded upon shipment to customers. We also record certain non-cash consideration given to customers for trade allowance programs as a reduction of sales in our statements of operations. We have not experienced any material differences between the trade allowance accruals and actual trade allowances. Shipping and handling costs are not billed to the customers.

Sales Returns
 
Retailers may be permitted to return their unsold products. The Company regularly reviews and revises, as deemed necessary, its estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we have considered, and will continue to consider, include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. The Company records estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations. Returns and allowances aggregated $93,156 and $1,055,786 for the three and nine month periods ended September 30, 2013. Returns and allowances aggregated $276,797 and $425,168 for the three and nine month periods ended September 30, 2012.
 
 
9

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
International Sales

All sales are invoiced in U.S dollars and all customer payments are received in U.S. dollars. The Company believes that we are not subject to foreign currency related risks.
 
Payments to Customers
 
The Company records revenues generated from sales with gift with purchase (GWP) promotions as sales. Costs of the gifts with purchase are reflected in selling, general and administrative expenses. Certain other incentive arrangements require the payment of a fee to customers based on their attainment of pre-established sales levels. These fees have been recorded as a reduction of net sales.
 
Segment Reporting

The Company has one reportable segment manufacturer: Distribution of fragrances and fragrance related products. The Company has a small number of customers and accordingly, the chief decision-maker monitors the revenue streams by customer. Operations are managed and financial performance is evaluated on a Company-wide basis, and accordingly, we are managed as one segment, rather than multiple segments for internal purposes and for internal decision making.

Advertising and Promotion
 
Advertising and promotional costs are expensed as incurred and recorded as selling, general and administrative expenses. Advertising and promotional costs included in selling, general and administrative expenses were $242,998 and $883,642 for the three months ended September 30, 2013 and 2012, respectively, and $1,931,617 and $1,713,043 for the nine months ended September 30, 2013 and 2012, respectively. Costs relating to gift with purchase promotions that are reflected in selling, general and administrative expenses aggregated $2,563 and $118,785 for the three months ended September 30, 2013 and 2012, respectively, and $317,709 and $224,120 for the nine months ended September 30, 2013 and 2012, respectively.

License Agreements
 
The Company’s license agreements provide the Company with worldwide rights to manufacture, market and sell fragrance and fragrance related products using the licensors’ trademarks. The licenses typically have an initial term of five years, and are potentially renewable subject to the Company’s compliance with the license agreement provisions. The remaining terms, including the potential renewal periods, range from approximately four years to five years. Under each license, the Company is required to pay royalties of five percent to the licensor, based on net sales to third parties at least quarterly.

Certain license agreements may require minimum royalty payments, incremental royalties based on net sales levels and minimum spending on advertising and promotional activities. Royalty expenses are accrued in the period in which net sales are recognized while advertising and promotional expenses are accrued at the time these costs are incurred.

In addition, the Company is exposed to certain concentration risk. Substantially all of our prestige fragrance brands are licensed and our business is dependent upon the continuation and renewal of such licenses.

 
10

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

Stock Based Compensation

The Company records stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock Compensation”, which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. Under ASC Topic 718, we recognize an expense for the fair value of our outstanding stock options and grants as they vest, whether held by employees or others.

Accounting and Reporting of Discontinued Operations

As required by the FASB ASC Subtopic 205-20, Discontinued Operations, the sales of certain income producing assets are classified as discontinued operations if (i) the operations and cash flows of the component have been, or will be, eliminated from the ongoing operations of the Company as a result of the disposal transaction and (ii) the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction. Certain income-producing properties that are classified as “held-for-sale” under the requirements of ASC Subtopic 205-20 are also treated as discontinued operations. Depreciation on these assets ceases upon their classification as “held-for-sale”.

Contingencies

Loss contingencies are accrued if the loss is probable and the amount of the loss can be reasonably estimated. Legal costs associated with potential loss contingencies are expensed as incurred.

Income Taxes
 
The Company recognizes deferred tax assets and liabilities for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If it is more likely than not that some portion of a deferred tax asset will not be realized, a valuation allowance is recognized.

Earnings Per Share

Basic and diluted loss per common share have been computed by dividing the losses applicable to common stock by the weighted average number of basic and diluted common shares outstanding. The Company’s basic and fully diluted EPS calculation for the three and nine month periods ending September 30, 2013 and 2012 are the same as the increased number of shares that would be included in the dilutive calculation from assumed exercise of common stock equivalents, warrants and convertible debt would have been antidilutive as a result of the net loss in each of the periods shown. The potential dilution at September 30, 2013 and 2012 is approximately 944,850 and 319,850 shares, respectively.

Comprehensive Income

Comprehensive income is generally defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. Comprehensive income is the total of net income and all other non-owner changes in equity. Items that are to be recognized under accounting standards as components of comprehensive income are displayed in statements of shareholders' equity. The Company had no material components of comprehensive income to be reclassified at September 30, 2013 and 2012, respectively.
 
 
11

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
Fair Value of Financial Instruments
 
In accordance with ASC 820, the carrying value of cash and cash equivalents, accounts receivable, accounts payable, and other short-term debt approximates fair value due to the short-term maturity of these instruments. ASC 825, "Fair Value Option" permits an entity to choose to measure many financial instruments and certain other items at fair value at specified election dates. Subsequent unrealized gains and losses on items for which the fair value option has been elected will be reported in earnings. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.
 
The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable, short-term and related party loans and notes approximate fair value due to the short-term maturity of these instruments. The Company has determined the fair value of convertible debt based on level 3 inputs.

Fair values are not available for the Company's loans from affiliates nor are fair values of similar loans available. The Company assessed that the fair value of this liability approximates its carrying value. The method described above may produce a current fair value calculation that may not be indicative of net realizable value or reflective of future fair values. If a readily determined market values became available or if actual performance were to vary appreciably from assumptions used, assumptions may need to be adjusted, which could result in material differences from the recorded carrying amounts. The Company believes its method of determining fair value is appropriate and consistent with other market participants. However, the use of different methodologies or different assumptions to value certain financial instruments could result in a different estimate of fair value.
 
Non-financial assets such as intangible assets and property, plant, and equipment are measured at fair value only when an impairment loss is recognized. The Company did not record an impairment charge related to these assets in the first nine months of 2013 or fiscal-year 2012.
 
Subsequent Events
 
The Company follows the guidance in Section 855-10-50 of the FASB for disclosure of subsequent events. The Company evaluates subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB ASC, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users such as filing them on EDGAR.
 
Operating Leases
 
The Company’s office lease expires January 31, 2014. The annual lease commitment is $58,400 and $4,900 for 2013 and 2014, respectively.

Recent Accounting Pronouncements

New accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standards setting bodies that we adopt according to the various timetables the FASB specifies. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.
 
2.  Going Concern
 
The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern. The Company has significant operating losses since inception which raise substantial doubt about the Company’s ability to continue as a going concern. As shown in the accompanying condensed financial statements, the Company has incurred net losses of $3.7 million and $3.0 million in the first nine months of 2013 and 2012, respectively. In addition as described in Note 11 Commitments and Contingencies, we were involved in litigation that resulted in the termination of a license. The operations of the Company have been funded through loans, related party borrowings, customer deposits, contributed capital, factoring and obtaining operating services from vendors. Management’s plans to generate cash flow during 2013 include expanding the Company’s operations through building new relationships and entering into new license agreements to introduce new fragrance lines and raising additional capital through debt or equity offerings and continue to obtain operating services from vendors in an effort to fund the Company’s anticipated expansion. There is no assurance additional capital or debt financing will be available to the Company on acceptable terms. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.
 
 
12

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

3. Inventories
 
Inventories consist of the following:

   
September 30,
2013
   
December 31,
2012
 
             
Inventories in transit
 
$
562,899
   
$
371,221
 
Raw materials
   
1,271,571
     
98,426
 
Finished goods
   
556,073
     
202,062
 
   
$
2,390,543
   
$
671,709
 
 
At September 30, 2013, the Company wrote-down inventory of $432,000 relating to the Selena Gomez settlement.  See Note 11 Commitments and Contingencies.

4.  Equipment
 
Equipment consists of the following:

   
September 30,
2013
   
December 31,
2012
 
             
Equipment
 
$
272,000
   
$
241,513
 
Less accumulated depreciation
   
(74,611
)
   
(21,455
)
Equipment, net
 
$
197,389
   
$
220,058
 

Depreciation expense included in continuing operations aggregated $29,523 and $3,787, and $88,764 and $3,787 for the three and nine month periods ended September 30, 2013 and 2012, respectively.

During the third quarter, the Company disposed of molds with a net book value of $87,805 relating to the Selena Gomez settlement.  See Note 11 Commitments and Contingencies.
 
5.  Accrued liabilities 
 
Accrued liabilities consist of the following:
 
   
September 30,
2013
   
December 31,
2012
 
             
Manufacturing fees
 
$
422,603
   
$
422,603
 
Deferred merchandise credit
   
542,601
     
646,808
 
Accrued royalties
   
179,026
     
-
 
Accrued retail returns
   
543,488
     
508,868
 
Accrued rent relating to former retail stores
   
1,385,335
     
1,385,335
 
Trade, construction payables and gift cards relating to former retail stores
   
812,532
     
849,054
 
Product returns
   
304,418
     
240,867
 
Other
   
351,997
     
161,810
 
    Total  
 
$
4,542,000
   
$
4,215,345
 
 
The above table includes approximately $2.2 million for amounts owed to trade and construction vendors and landlords relating to the Company’s former retail business, some of these liabilities are over four years old. The Company has had little or no communication from these vendors or landlords. The Company and its counsel believe that in the future, and as a result of future negotiations, the statute of limitations and other factors, these amounts may be reduced.
 
 
13

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
6. Loans Payable, and stockholder notes

Loans payable, short term

Loans payable were $463,076 as of September 30, 2013 and $230,000 as of December 31, 2012, and consists of the following:

During May 2008, the Company signed a $400,000 promissory note with a third party.  The note bears interest at 9% per year. The loan had an original maturity of August 2008, is in default, and the outstanding balance of $230,000 is shown as current.

On August 7, 2013, the Company signed a $230,000 promissory note with a third party. The note is unsecured, bears no interest, with $100,000 to be repaid within 14 days and $130,000 to be repaid within 180 days.  The Company repaid $100,000 during September 2013 and borrowed an additional $103,076 on September 27, 2013, due in 180 days, leaving an outstanding balance of $233,076 at September 30, 2013, which is shown as current.

Loans payable, long term

In November 2012, the Company along with its chairman CEO principal shareholder guaranteed the repayment of a $1.2 million borrowing of Gigantic Parfums, LLC, (Gigantic) a company under common control, from Parfums Investment, LLC.  The loan provides for monthly payments of interest only at 20% per year and is due in November 2016.  The Company secured substantially all of its assets to the lender.  The balance on this obligation was $900,000 at September 30, 2013.
 
As a result of Gigantic winding down its business activities, essentially the Company became the primary obligor of the debt and accordingly assumed the $900,000 debt to Parfums Investments and reduced $900,000 of its debt to Gigantic as of September 30, 2013.
 
Related party and stockholder notes

   
Interest Rates
   
September 30,
2013
   
December 31,
2012
 
                   
Chairman CEO principal shareholder note (a)
   
5
%
 
$
1,505,147
   
$
1,765,655
 
Shareholder notes (b)
   
0 - 12
%
   
1,128,102
     
848,281
 
Related party loans (c)
   
0
%
   
117,089
     
-
 
Total related party and stockholder notes
         
$
2,750,338
   
$
2,613,936
 
Current portion of related party and stockholder notes
           
99,930
     
2,613,936
 
Long-term portion of related party and stockholder notes
         
$
2,650,408
   
$
-
 

(a)  
The chairman CEO principal shareholder note is payable in 35 payments of $94,121, commencing November 1, 2010 at 5%. The note is due October 1, 2013. Interest expense for the three and nine month periods ended September 30, 2013 was $20,244 and $61,319. On September 30, 2013, the Company renegotiated the due date of this note to December 31, 2015.  The balance is shown as long-term at September 31, 2013.
 
(b)  
For periods through June 30, 2013, certain of the Company’s loans were in default or due in one year of less and therefore shown as current. On September 30, 2013, the Company renegotiated due dates of December 31, 2015 for five Shareholder notes.  A total of $1,028,173 was reclassified from short-term to long-term at September 30, 2013.
 
During September 2013, a related party converted $200,000 of non-interest bearing customer deposits into a $200,000, 12% Shareholder note with no specific repayment terms.  The note is due December 15, 2015 and is shown as long-term.

(c)  
For periods through June 30, 2013, there was no note in connection with the related party loan, and the balance was shown as current. On September 30, 2013, the Company negotiated a due date of December 31, 2015 and therefore, at September 30, 2013, the balance is shown a long-term.

 
 
14

 
 
Minimum future loans and related party and stockholder notes annual payments are as follows:
 
2014
 
$
563,636
 
2015
   
2,650,408
 
2016
   
900,000
 
Total
 
$
4,114,044
 
 
7. Note payable related party

In January 2013, the Company borrowed $560,000 from a company controlled by the Chairman CEO principal shareholder of the Company. The loan is secured by property personally owned by the Chairman CEO principal shareholder and provides for monthly payments of interest only at 10% per year. The loan is due in January 2014.

8. Convertible debenture
 
On March 8, 2013, the Company issued a $500,000 face value 12% convertible debenture which matures on February 28, 2014. The debenture is convertible into shares of the Company’s common stock at $4 per share. The interest is payable monthly at 12% per annum. At the maturity date, the holder may:
 
(a)  
request repayment in cash of the outstanding principal balance.  If during the term the holder requests payment solely in cash, then the holder will receive an additional $100,000 (the incentive fee), 60 days following the maturity date. No incentive fee will be paid if the holder receives inventory or Company common stock, or
 
(b)  
convert all or any portion of the outstanding principal balance into common stock at the then prevailing conversion ratio. If during the term or at maturity the holder converts 100% of the principal balance, they will be issued an additional 60% of the Company conversion shares.  Additional shares will not be issued unless the holder converts 100% of the principal amount into common shares, or
 
(c)  
request delivery to the holder of $1 million of the Company’s current inventory of marketable, licensed fragrances. The dollar value of the inventory will be based on the Company’s distributor price list as of the maturity date.
 
As a result of the foregoing options, the Company has elected in accordance with ASC 815-15-30 to make a fair value election for Hybrid Financial Instruments and will initially measure and subsequently measure the instrument at fair value.  At September 30, 2013, the resulting derivative liability ($56,530) and the debenture were valued at $556,530.
 
 
15

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

9.  Short term advances - related party

During the second quarter, the Company received short term advances from a related party totaling $1.3 million. There is no stated interest rate or repayment terms. The balance of $548,826 at September 30, 2013, includes both cash advanced and discounts earned and is shown as current as the Company expects to repay the advance June 30, 2014.

10.  Warrants

On August 12, 2013, the Company issued a stock warrant to one of its customers, who also provides financing to the Company, to purchase up to 500,000 shares of common stock with an exercise price of $4.00 per share. The warrants are exercisable immediately and expire August 31, 2018.  The warrants were valued at $100,000, as determined by an independent valuation specialist, and are considered a sales incentive, in accordance with ASC 650-50. The Company recognized a $100,000 reduction of sales and credited paid-in-capital.

11. Commitments and Contingencies

Leases
 
The Company’s rent expense for its office facilities in Hallandale and other space in Los Angeles amounted to approximately $54,000 and $49,000 for the three months ended September 31, 2013 and 2012, respectively, and $161,000 and $49,000 for the nine months ended September 31, 2013 and 2012, respectively.  There was no rent expense for the first six months of 2012. In the past, certain of the Company’s lessors provided the Company with lease incentives and were recorded as deferred lease incentives on the balance sheet in prior years. Certain of the Company's lease commitments are guaranteed by the principal officer/shareholder and other family members.

On September 30, 2011, the Company formally decided to discontinue its retail store operations that sold active sportswear, and to close, abandon, dispose or sell its assets relating to its retail operations. The Company decided to dispose of its retail stores because it incurred significant operating losses and was unable to sustain a viable business model for the past six years. At December 31, 2011, one retail store was operating which was subsequently sold in the third quarter of 2012.
 
Management, and based on the opinion of counsel, believe that the Company is not obligated for any lease payments beyond the termination dates, nor obligated to return the lease incentives or lease concessions previously given to the Company in prior years, which aggregates $12.6 million. Management along with the Company’s counsel believes that any amount or range of a potential liability cannot be reasonably estimated at this time.
 
License Agreements
 
The Company is party to a number of license and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2018. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2012, without consideration for potential renewal periods. The amounts set forth below do not reflect the fact that our distributors share our advertising obligations. Royalty expense included in selling, general, and administrative expenses, aggregated $181,218 and $587,661 for the three and nine months ended September 30, 2013, respectively, and $125,000 and $208,333 for the three and nine months ended September 30, 2012, based on a percentage of net sales or a minimum, as defined.

Exclusive License Agreements 

In July 2011, the Company entered into an exclusive fragrance licensing agreement to develop, manufacture and distribute fragrances under the Selena Gomez trademark. The initial term of the agreement expires in 2017, and is renewable for an additional five-year term if certain sales levels are met. The Company is required to pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. Payment of the minimum royalties is guaranteed by the chairman CEO principal shareholder and by another company that he controls. Sales under this license accounted for 35% of sales for the first nine months of 2013.
 
 
16

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
On March 21, 2013, the Company received notice that it was in breach of this license. The license was terminated September 9, 2013 without further liability to either party. See Commitments and Contingencies below.
 
In January 2012, the Company entered into an exclusive fragrance licensing agreement to develop, manufacture and distribute fragrances under the Adam Levine trademark. The initial term of the agreement expires in 2018, and is renewable for an additional five-year term if certain sales levels are met. The Company is required to pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. Payment of the minimum royalties is guaranteed by a company that is controlled by the chairman CEO principal shareholder of the Company. Sales under this license accounted for 65% of sales for the first nine months of 2013.

On October 1, 2013, the Company entered into an exclusive license agreement (the “License Agreement”) with Kendall Jenner Inc. (the “Licensor”).   See Subsequent Events.
 
In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments as follows:
 
2013
 
$
4,200,000
 
2014
   
6,300,000
 
2015
   
7,600,000
 
2016
   
10,600,000
 
2017
   
13,600,000
 
Total
 
$
42,300,000
 
 
The Company has granted a security interest in certain licenses in connection with a note payable.
 
Manufacturing, Supplier and Distribution Agreements
 
Effective July 2011, the Company entered into an exclusive supplier agreement for the purchase of raw materials for one of its fragrance products through 2016. The agreement provides, in part for purchase price reduction upon sales volumes, as defined. In this connection, the Company recorded a deferred merchandise credit on the accompanying balance sheet. The Company is recognizing such deferred credit ratably in cost of sales. In February 2013, the agreement was modified to provide that in the event the Company sells or transfer its fragrance licensing rights, it will cause to be included in any subsequent agreement a requirement that the buyer continue to exclusively use this supplier.

In November 2011, the Company entered into a manufacturing agreement whereby the vendor was entitled to a manufacturing management fee equal to a percentage of cost of goods sold, with a pre-defined minimum fee. Also, in November 2011, the Company entered into a distribution agreement with the same company that manufactures its fragrance products. The agreement provides for this vendor to provide warehouse, logistic and administrative services. In accordance with the agreement, the vendor is entitled to a minimum guarantee management fee of $812,500 based on sales and other fees, as defined, based on volume of customers processed, per unit costs, hourly rates for assembly, handling, etc. incurred by this vendor. Both agreements are for one year with an automatic renewal, unless either party provides written notice of termination, as defined. In addition, the Company is required to grant a security interest in the products, as defined, to this vendor. In August 2012, the Company provided written timely notice of termination, and accordingly, the Company received notice that it owes certain minimum fees. In this connection, the Company has recorded approximately $423,000 on the accompanying balance sheets at September 30, 2013 and December 31, 2012. In addition, the Company received notice alleging a breach of the manufacturing agreement. This vendor owns finished goods and components aggregating approximately $1.7 million at December 31, 2012. The agreement provides that if, the Company does not purchase the finished goods and components within 15 days of termination, the vendor has the right to sell the remaining inventory at wholesale prices. The Company does not believe it owes or is committed to purchase the balance of the remaining finished goods and product components at December 31, 2012, based on its contract terms. Management along with the Company’s counsel believe that any amount or range of a potential liability cannot be reasonably estimated at this time.
 
 
17

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

On March 21, 2013 the Company was informed that the aforementioned supplier filed a lawsuit against the Company. The Company has retained counsel and is contesting this matter. See Litigation below.

In September 2012, the Company signed a new warehouse and distribution agreement for one year, effective January 1, 2013, with renewals as agreed by both parties. The agreement provides for this vendor to provide order fulfillment, warehouse, logistic and administrative services. In accordance with the agreement, the vendor is entitled to fees, as defined, based on volume of customers processed, per unit costs, hourly rates incurred by this vendor.

Litigation

On March 11, 2013 Victory International (USA) LLC (“Victory”) filed a lawsuit against ID Perfumes.  The lawsuit was filed in the United States District Court, District of New Jersey (Civil Action No. cv-01465-FSH-PS).  The lawsuit seeks damages in excess of $1.2 million as well as injunctive relief.  We have filed affirmative defenses and a counterclaim against Victory for breach of contract. We are seeking compensatory, consequential and economic damages in excess of $45 million.  (See Company’s Form 10-Q filed August 14, 2013 and on May 20, 2013 for additional information.)

As reported in the Company’s Form 8-k filed September 17, 2013 we have settled the lawsuit which we filed against Selena Gomez and July Moon Productions.  With the execution of the Settlement Agreement and Mutual Release, the Licensing Agreement with Selena Gomez has been terminated. The Company recognized a net gain of $65,454 in connection with the Settlement Agreement. The Company filed a Form 8-k on September 17, 2013 reporting the settlement.
 
 
18

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
12. Share-Based Compensation and Stock Incentive Plan
 
In November 2008, the Company's shareholders approved the 2008 Incentive Plan (the "Plan"), which has initially reserved 5,000,000 shares of Common Stock for issuance. The 2008 Incentive Plan permits the grant of stock options, restricted stock, restricted stock units and other forms of stock-based compensation to selected persons providing services to the Company (including non-employee directors). Under the 2008 Incentive Plan, options may be granted which are intended to qualify as Incentive Stock Options under Section 422 of the Internal Revenue Code of 1986 (the "Code") or which are not intended to qualify as Incentive Stock Options thereunder.

In connection with the Plan, in January 2009 the Company granted 26,100 options to employees and directors valued at $130,171. The options vested over 4 years and the option value was recorded as deferred compensation upon grant date and compensation expense was recognized through 2012.

On August 17, 2012, the Company granted 300,000 options to an officer of the Company valued at $.18 per share. The option is exercisable at $0.75 per share and vests immediately. The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.
 
Stock price
 
$
0.31
 
Expected life (years)
   
5.0
 
Expected volatility
   
95.0
%
Risk-free interest rate
   
0.62
%
Dividend yield
   
0.0
%
 
The expected life of options represented the estimated period of time until exercise based on expectations of future behavior. The expected volatility was estimated using the historical volatility of the Company's stock which management believes is the best indicator at this time. The risk-free interest rate was based on the implied yield available on U.S. Treasury zero coupon issues with an equivalent term. The Company has not paid dividends in the past and does not intend to in the foreseeable future.

Share-based compensation aggregated $54,000 for the three and nine months ended September 30, 2012, respectively.  There was zero share-based compensation for the same periods of 2013.

 
19

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

The following table summarizes additional stock option information as of September 30, 2013.

Exercise price
   
Number outstanding
   
Options outstanding
weighted average
remaining contractual life
   
Options exercisable
 
$
5.00
     
19,850
     
5.5
     
19,850
 
$
0.75
     
300,000
     
9
     
300,000
 
Totals
     
319,850
             
319,850
 
 
As of September 30, 2013, the weighted average exercise price of options exercisable was $1.01 and the weighted average remaining contractual life of options exercisable was 8.76 years. The aggregate intrinsic value of options exercisable at September 30, 2013 is $0.

The following table summarizes stock option activity and related information for the nine month period ended September 30, 2013:

   
2013
 
   
Options
   
Weighted
 Average
 exercise
 price
 
Shares under option - beginning of year
   
319,850
   
$
1.01
 
Options granted
   
--
     
--
 
Options exercised
   
--
     
--
 
Options cancelled
   
--
     
--
 
Shares under options – September 30
   
319,850
     
1.01
 
 
 
20

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

13. Stock
 
Sales of unregistered shares and conversion of debt to common stock are as follows:

   
Number of Shares
 
   
2013
   
2012
 
Sales of unregistered Stock
   
15,000
     
15,000
 
Conversion of Debt to Common Stock
   
-
     
960,000
 
Total
   
15,000
     
975,000
 
 
In 2013, the sales of unregistered stock were sold at $4.00 per share. In 2012, the sales of unregistered stock were sold at $4.33 per share.
 
In November 2012, a company under common control converted debt with a face value of $960,000 at a $1.00 per share. The conversion price of the $960,000 of debt was in excess of the fair value of the common stock issued, as determined by an independent valuation specialist, and in accordance with ASC 470-50-40-2, such excess was credited to paid-in-capital.
 
14. Related Party Transactions
 
(a) 
ID Perfumes has significant transactions with a company that is under common control.

In January 2012, the Company entered into a service agreement whereby the affiliate provided selling, general, administrative, and production services that was cancelled in August 2012 and incurred fees of $124,000. Interest free advances and repayments are made between these entities. Effective August 2012, the Company has been paying $13,000 a month for rent relating to a lease that the affiliate entered into on the Company’s behalf. In this connection, there is no formal arrangement between the Company and the affiliate. The Company has assumed the lease.  In addition, ID Perfumes accepted product returns from this affiliate’s customers to maintain its business relationships with certain current customers of ID Perfumes aggregating $67,000 and $300,000 for 2013 and 2012, which reduced the amounts due this affiliate on the Company’s balance sheet. Amounts due this affiliate aggregated approximately $100,900 and $1,048,500 as of September 30, 2013 and December 31, 2012, respectively.

 
21

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
During 2012, this affiliate exchanged $960,000 of its debt for 960,000 shares of the Company’s common stock. In November 2012, the Company along with its chairman CEO principal shareholder and COO guaranteed the repayment of a $1.2 million borrowing of this affiliate, Gigantic Parfums, from Parfums Investment, LLC. The loan is secured by substantially all of the assets of the Company.  The loan provides for monthly payments of interest only at 20% a year, and the loan balance is due in 2016. The balance on this obligation was $900,000 at September 30, 2013.
 
As a result of Gigantic winding down its business activities, essentially the Company became the primary obligor of the debt and accordingly assumed the $900,000 debt to Parfums Investments and reduced $900,000 of its debt to Gigantic as of September 30, 2013.
 
In July 2013, the Company entered into a Membership Interest and Share Exchange Agreement which was subject to rescission.  The Agreement was rescinded in September 2013.
 
Effective July 2011, ID Perfumes entered into an exclusive supplier agreement with this affiliate. The agreement provides that the Company will be the exclusive fragrance supplier to the affiliate through August 2016 and the selling price to this affiliate will be the same price that the Company pays for its purchase of fragrance products, as defined. In July 2012, the affiliate sold its license and as a result, sales to this affiliate ceased. In this connection, sales to the affiliate aggregated $15,962 and $511,576 for the three and nine month periods ended September 30, 2012. There were no sales to this affiliate for the first nine months of 2013.
 
(b)  
In 2009, a company under common control acquired the membership interests of ID Perfume’s four media and publishing subsidiaries. Further, the affiliate signed a five year lease in June 2011 for approximately 1,500 square feet with the landlord for store premises located in San Diego and subleased the store to the Company. In this connection, rent expense aggregated $0 and $13,000 in 2013 and 2012, respectively and is included in discontinued operations. The store was used to sell the Company’s sports products. In addition, on September 1, 2012, ID Perfume’s last store and the related business operations were sold to this affiliate in exchange for assumption of the related affiliated debt aggregating $166,000, which resulted in the termination of the sublease and a gain of $63,000 which was reflected in discontinued operations during the third quarter of 2012.

(c)  
In January 2012, the Company entered into a distribution agreement to sell its products in Mexico with a company owned by the brother of the Company’s chairman CEO principal shareholder. Among other things, the agreement provides that the distributor is entitled to reimbursement equal to the greater of a defined minimum or a percentage of spending on advertising and promotional activities incurred by the distributor. In this connection, the Company incurred $44,000 and $88,000 for the three and nine month periods ended September 30, 2012. There were no reimbursement expenses for the first nine months of 2013. During the three and nine months ended September 31, 2013, sales to this company aggregated $41,987 and $74,487, and during the three month and nine month periods ended September 30, 2012, sales to this company aggregated $49,500. During March 2013, the above mentioned marketing allowance was modified to provide an allowance of 10% of net yearly purchases.

(d)  
ID Perfumes sells to a company that is owned by an individual that owns shares of ID Perfume’s common stock. In this connection, sales to this company aggregated $94,000 and $709,000 for the three and nine month periods ended September 30, 2013. Sales to this company were $3,600 during the three and nine month periods ended September 31, 2012. This individual has also made loans to the Company. As of September 30, 2013 and December 31, 2012, $1.2 million and $453,000 is owed to this individual for principal and interest for the debt and short term borrowings. In addition, ID Perfumes has received deposits for future sales aggregating $712,000 and $1.2 million from this related party as of September 30, 2013 and December 31, 2012, respectively.

Since inception, the Company has borrowed significant amounts of money from the Company’s chairman CEO principal stockholder, affiliates and family. Attention is directed to the footnote 6 “Loan payable and stockholder notes” and footnote 7 “Note payable related party” for more information concerning these borrowings.

 
22

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)

In January 2013, the Company borrowed $560,000 from a company controlled by the chairman CEO principal shareholder of the Company. Among other things, the loan is secured by property personally owned by the Chairman CEO principal shareholder, provides for interest at 10%, and is due in January 2014.

In January 2013, the Chief Operating Officer advanced the Company $130,000.

In February 2013, a family member of the chairman CEO principal shareholder of the Company loaned ID Perfumes $110,000.  The loan bears no interest and is due in one year.

In May 2013, a family member of the chairman CEO principal stockholder of the Company loaned ID Perfumes $100,000. The loan bears no interest and is due in one year.

15.  Mergers and Acquisitions

On July 11, 2013, the Company entered into a Membership Interest and Share Exchange Agreement with Gigantic Parfums LLC, a company under common control, whereby the Company agreed to exchange 253,125 shares of its common stock for all the issued and outstanding membership interests of Gigantic, subject to rescission within 75 days. Information regarding this acquisition is contained in the Company’s Form 8-k filed with the Securities and Exchange Commission on July 17, 2013.

On September 23, 2013 ID Perfumes, Inc. entered into a Rescission Agreement with Gigantic Parfums Inc. and those members of Gigantic who were signatories to the Membership Interest and Share Exchange Agreement (the “Share Exchange Agreement”) dated July 11, 2013 and filed as an exhibit to the Company’s Form 8-k filed with the Securities and Exchange Commission on July 17, 2013.  The Rescission Agreement provides in part that that the terms and conditions as set forth   in the Share Exchange Agreement shall be deemed fully rescinded and the respective benefits, liabilities or obligations imposed under the Share Exchange Agreement shall be cancelled and made void.  The Company filed an 8-k with the Securities and Exchange Commission on September 25, 2013.

16.  Variable interest entities

Two of the Company’s business affiliates are considered variable interest entities (VIE’s), as defined in ASC 810. The Company is not considered the primary beneficiary of, and therefore does not consolidate any of the VIE’s in which it holds a variable interest. The Company’s involvement with one of its VIE’s consisted of borrowing funds from the VIE, of which the balances at September 30, 2013 and December 31, 2012 were $100,919 and $1,048,488, respectively, and certain sales to the VIE. Additionally, the VIE made an equity investment in the Company and provided administrative services to the Company during 2012. Further, to maintain its business relationships with certain customers, the Company accepted $67,000 and $300,000 of the VIE’s product returns in June 2013 and December 2012, respectively.
 
The Company sold its last retail location to the other VIE during the third quarter of 2012. There was no activity with this VIE during 2013.

17. Discontinued Operations
 
On September 30, 2011, the Company formally decided to discontinue its retail store operations that sold active sportswear, and to close, abandon, dispose or sell its assets relating to its retail operations. The Company decided to dispose of its retail stores because it incurred significant operating losses and was unable to sustain a viable business model for the past six years. As a result of the discontinuance of the operations, in 2011 the Company recognized a gain on two of its disposals of its stores aggregating approximately $2.3 million, of which $4.7 million results from the reversal of deferred lease incentives and deferred rent recorded in prior years. In prior years, impairment losses relating to the stores were written down to fair value prior to the sale. Furthermore, on November 22, 2011, the Company sold the assets of one store consisting of inventory, equipment and improvements to a company owned and/or operated by a former employee for approximately $36,000 plus the assumption of certain liabilities for the same amount. The abandoned store is currently operated by the former employee. The third store was sold in 2012 for the assumption of approximately $166,000 of liabilities to an affiliate that resulted in a gain on disposal of approximately $63,000 during the third quarter of 2012.
 
 
23

 
 
ID PERFUMES, INC.
Notes to Condensed Financial Statements
(Unaudited)
 
Retail sales, reported in discontinued operations for the three and nine month periods ended September 30, 2012 aggregated $37,409 and $106,207. In this connection, pre-tax losses reported in discontinued operations for the three and nine month periods ended September 30, 2012 aggregated $63,147 and $444,255, including gain on disposal – related party of $63,223 for both periods.  There were no discontinued operations balances for 2013.

In accordance with ASC 230-10-45-24, the Company has elected not to separately disclose cash flows from discontinued operations.
 
18. Segments and Geographic Areas
 
The Company manufactures and distributes one product line, fragrances and fragrance related products. Related party sales aggregated 6.9% and 8.9% of sales in the three and nine month periods ended September 30, 2013 and 2.6% and 13.7% for the three and nine month periods ended September 30, 2012. There are no assets located in Europe, Canada, or the Middle East. We have assets (Molds) in Asia.

The following tables present our geographic sales information:

   
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2013
   
2012
   
2013
   
2012
 
United States and the Caribbean
  $ 1,443,350     $ 2,750,290     $ 4,623,158     $ 4,142,996  
Latin America
    41,987       49,500       295,142       49,500  
Canada
    447,816       -       885,363       -  
Europe
    34,948               34,948          
Middle East and Southeast Asia
    -       -       199,872       -  
                                 
Total
  $ 1,968,101     $ 2,799,790     $ 6,038,483     $ 4,192,496  

19. Subsequent Events

On October 1, 2013, the Company entered into an exclusive license agreement (the “License Agreement”) with Kendall Jenner Inc. (the “Licensor”).   The License Agreement was effective September 23, 2013 and grants ID Perfumes the worldwide right to use the trademark “Kendall Jenner” including but not limited to her name, likeness, image, voice and other attributes of her personality and the right to provide services in connection with the license. The initial term of the agreement expires in 2018, and is renewable for an additional five-year term if certain sales levels are met. The Company is required to pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume.

On October 3, 2013, the Company signed a $670,000 promissory note with a third party. The note bears interest at 20% and is due in one year.  The note is collateralized by all inventory, equipment, supplies, certain receivables, royalties receivable related to the July Moon, Inc. settlement and the Kendall Jenner license.

During October and November 2013, the Company borrowed an aggregate of $230,000 from related parties.  The loans bear interest from 5%-6% with $100,000 due in one year and $130,000 due December 15, 2015.

 
24

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
 
Cautionary Note about Forward-Looking Statements
 
Forward-Looking Statements

We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this Quarterly Report on Form 10-Q or made by our management involve risks and uncertainties and are subject to change based on various important factors, many of which may be beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Accordingly, investors should not place undue reliance on forward-looking statements as a prediction of actual results. You can identify these statements as those that may predict, forecast, indicate or imply future results, performance or advancements and by forward-looking words such as “believe,” “anticipate,” “expect,” “estimate,” “predict,” “intend,” “plan,” “project,” “will,” “will be,” “will continue,” “will result,” “could,” “may,” “might” or any variations of such words or other words with similar meanings. Forward-looking statements address, among other things, our expectations, our growth strategies, including our plans to expand our perfume line and distribution channels, increase profit margins and return on invested capital, projections of our future profitability, results of operations, capital expenditures or our financial condition or other “forward-looking” information and includes statements about revenues, earnings, spending, margins, liquidity, inventory, private label products, our actions, plans or strategies. We are including this cautionary statement in this report to make applicable and take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 for any forward-looking statements made by, or on behalf, of us.

Important factors that may cause actual results to differ from projections include, for example:
 
-
the success or failure of management's efforts to implement the Registrant's plan of operation;
-
the ability of the Registrant to fund its operating expenses;
-
the ability of the Registrant to compete with other companies that have a similar plan of operation;
-
the effect of changing economic conditions impacting our plan of operation;
-
the ability of the Registrant to meet the other risks as may be described in future filings with the SEC.

In addition, we operate in a highly competitive and rapidly changing environment; therefore, new risk factors can arise, and it is not possible for management to predict all such risk factors, nor to assess the impact of all such risk factors on our business or the extent to which any individual risk factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. We do not assume any obligation and do not intend to update any forward-looking statements except as may be required by securities laws.

General

The following analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements, including footnotes, and other information presented elsewhere in this report.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand our results of operations and financial condition.

Our Business

We manufacture, distribute, market, promote, and sell perfumes and related products licensed through celebrities. Our objective is to develop and launch quality fragrances utilizing nationally recognized celebrities to endorse our product offerings.   In furtherance thereof we signed exclusive licensing agreements with Selena Gomez and Adam Levine.  Our fragrances are marketed under the “ID” company name.   Copies of the Selena Gomez and Adam Levine agreements were filed as exhibits to our Registration Statement filed on Form 10 with the Securities and Exchange Commission on April 30, 2013.

The Selena Gomez agreement was terminated in September 2013 without further liability to either party.

Subsequent to the quarter ended September 30, 2013 on October 1, 2013 we entered into an exclusive licensing agreement with Kendall Jenner.  The License Agreement was effective September 23, 2013 and is for a term of five years.  The license grants ID Perfumes the worldwide right to use the trademark “Kendall Jenner” including but not limited to her name, likeness, image, voice and other attributes of her personality and the right to provide services in connection with the license.

A copy of the Kendall Jenner agreement was filed as an exhibit to our Form 8-k filed October 4, 2013
 
 
25

 
 
Our marketing efforts focus principally on promoting the quality, value and benefits of our products. Each of our licensed fragrances are distinctively positioned, have a single image. We may expand our operations through the creation of fragrance family extensions.  Our goal is to create a new family of fragrances for each of our licensed brands.  We may introduce seasonal brands as well.
 
Adam Levine
 
We launched Adam Levine's debut fragrance for men and women in February 2013. The initial launch event was combined with a range of events including a group of Adam Levine Personal Appearances to promote, build awareness, and stimulate sales for the brand globally. We partnered with Commonwealth Projects to develop a proprietary "POP-UP" installation in the center of Los Angeles, California for one (1) week.

Kendall Jenner

On October 1, 2013, the Company entered into an exclusive license agreement with Kendall Jenner Inc. The License Agreement was effective September 23, 2013 and grants ID Perfumes the worldwide right to use the trademark “Kendall Jenner” including but not limited to her name, likeness, image, voice and other attributes of her personality and the right to provide services in connection with the license. ID will be responsible for the design, manufacture, marketing, distribution and sale of the Kendall Jenner fragrances for women and children.  ID Perfumes also has the right to request from the Licensor the licensing rights for a line of men’s fragrances.  ID Perfumes also has the non-exclusive right to market scented personal beauty products for men, women and children  but only with a  “Gift with Purchase” package or gift set  and full sized sellable fragrance ancillaries (i.e. body lotion, shower gel, body mist, deodorants, creams, powders and/or other fragrance). The anticipated launch of our first Kendall Jenner fragrance is May 2014.
 
Production and Supply for our fragrance lines
 
The launch of a new fragrance line involves input from many different sources, from perfume designers to glass makers.
 
The stages of the development and production process can be summarized as follows:
 
 
Discussions with perfume designers and creators (includes analysis of esthetic and factory trends, target clientele and market communication approach);
 
Concept choice;
 
Produce mock-ups for final acceptance of bottles and packaging;
 
Receive bids from component suppliers (glass makers, plastic processors, printers, etc.) and packaging companies;
 
Choose suppliers;
 
Schedule production and packaging;
 
Issue component purchase orders;
 
Follow quality control procedures for incoming components; and
 
Follow packaging and inventory control procedures.
 
Fragrance manufacturers rely on multiple suppliers to manufacture their fragrances including:
 
 
Independent perfumery design companies;
 
Perfumers which create a fragrance consistent with our expectations and, that of the fragrance designers and creators;
 
Contract manufacturers of components such as glassware,  caps or boxes ;
 
Production specialists who carry out packaging or logistics for storage, order preparation and shipment.
 
Marketing Strategies
 
Our marketing efforts will focus principally on promoting the quality, value and benefits of our products.  Each of our licensed fragrances will be distinctively positioned, have a single image, and will be promoted with consistent logos, packaging and advertising designed to enhance its image and differentiate it from other brands.  We will regularly advertise our products on television and radio, in upscale magazines and newspapers, the Internet, and through direct mail.  We intend to leverage social networking, mobile, and digital applications so that we are able to engage with our consumers through their preferred technologies. In addition, we believe that our fragrances will receive editorial coverage in prestige publications and other media outlets. 
 
 
26

 
 
Growth strategies and portfolio branding can be achieved through new product development and marketing  
 
We intend to grow through the creation of fragrance family extensions.  Our goal is to create a new family of fragrances for each of our licensed brands.  We may introduce “seasonal” fragrances as well. With new introductions, we leverage our ability and experience to gauge trends in the market and further leverage the brand name into different product families in order to maximize sales and profit potential. We will promote the smooth and consistent performance of our fragrance operations through knowledge of the market, detailed analysis of the image and potential of each brand name, a “good dose” of creativity and a highly professional approach to distribution channels.

Competition

The fragrance industry is highly competitive and can change rapidly due to consumer preferences and industry trends. Competition in this industry is based on brand strength, pricing and assortment of products, in store presence and visibility, innovation, perceived value, product availability, order fulfillment, service to the customer, promotional activities, advertising, special events, new product introductions, e-commerce and mobile commerce initiatives, and other activities.
 
We believe that we compete primarily on the basis of brand recognition, quality, product efficacy and price.

Production and Supply for our fragrance lines

The launch of a new fragrance line involves input from many different sources, from perfume designers to glass makers.
 
Contract manufacturers receive raw materials and components on our behalf, and conduct basic fill and assembly activities to convert materials into finished sellable items to be used to fulfill customer orders. In addition, these manufacturers may handle distribution services for warehousing, order processing, and customer service.
 
Product Liability

Like other retailers, distributors and manufacturers, we face an inherent risk of exposure to product liability or product recall claims.
 
We carry an umbrella product liability policy. In the event that we do not have adequate insurance, product liabilities relating to defective products could have a material adverse effect on our operations and financial conditions.
 
Employees

As of September 30, 2013 we had 19 full time and one part time employees.

 
27

 
 
Critical Accounting Policies and Estimates

Discussion of Critical Accounting Policies

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We do not have an independent Board of Directors. Our sole board member serves as our chief executive officer. As such, our chief executive officer must make both managerial and operational decisions on behalf of the Board of Directors.

Revenue Recognition

We sell our products to department stores, perfumeries, specialty retailers, mass-market retailers and domestic and international wholesalers and distributors. Sales of such products are denominated in U.S. dollars. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, trade discounts and allowances.

Accounts Receivable

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for sales returns, cooperative advertising and doubtful accounts or balances which are estimated to be uncollectable. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns.

Sales Returns

Generally, we permit our retail customers to return their unsold products if properly requested, authorized and approved. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we have considered, and will continue to consider, include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

Promotional Allowance

We have various performance-based arrangements with certain retailers. These arrangements primarily allow customers to take deductions against amounts owed to us for product purchases. The costs that our Company incurs for performance-based arrangements are netted against revenues on our Company’s statement of income. Estimated accruals for promotions and advertising programs are recorded in the period in which the related revenue is recognized. We review and revise the estimated accruals for the projected costs for these promotions. Actual costs incurred may differ significantly, either favorably or unfavorably, from estimates if factors such as the level and success of the retailers’ programs or other conditions differ from our expectations.

 
28

 
 
Inventory

Inventory is stated at the lower of cost or market value. Cost is principally determined by the average cost method. We record adjustments to the cost of inventory based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual requirements if future economic conditions or competitive conditions differ from our expectations.

Equipment and Other Long-Lived Assets

Equipment, consisting of molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

Income taxes

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently anticipated tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. In addition, the Company follows the provisions of uncertain tax positions as addressed in ASC topic 740-10-65-1.
 
Derivative Instruments

The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification and paragraph 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the Statement of Operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
 
In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
 
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.
 
Results of Operations

Three and Nine Months Ended September 30, 2013 compared to the Three and Nine Months Ended September 30, 2012

The following table sets forth the percentage relationship net sales to costs of sales for each of our reporting lines in our statements of operations. This table should be read in conjunction with the following discussion and with our condensed financial statements, including the related notes.

   
Three months ended
         
Nine months ended
       
   
September 30,
   
%
   
September 30,
   
%
 
   
2013
   
2012
   
Change
   
2013
   
2012
   
Change
 
Sales
  $ 1,968,101,     $ 2,799,790       (29.7 )%   $ 6,038,483     $ 4,192,496       44.0 %
Cost of sales
    1,325,772       1,643,667       (19.3 )%     3,135,968       2,428,521       29.1 %
Gross margin
  $ 642,329     $ 1,156,123       (44.4 )%   $ 2,902,515     $ 1,763,975       64.5 %
Gross margin as a percentage of sales
    32.6 %     41.3 %             48.1 %     42.1 %        
 
Revenues. Net Sales for the three months ended September 30, 2013 decreased $831,689 or (29.7)% as compared to the three months ended September 30, 2012, primarily due to the timing of new fragrance line launches.  The third quarter of 2012 had high sales related to the May 2012 launch of the Selena Gomez fragrance line.  Our February 2013 launch of our Adam Levine fragrance line provided strong second quarter 2013 sales that decreased slightly in the third quarter of 2013. The Company experienced strong second quarter 2013 sales relating to the launch. Such increase was net of $93,156 and $276,797 of sales returns for the three months ended September 30, 2013 and 2012, respectively. Net sales for the nine months ended September 30, 2013 increased $1,845,987 or 44.0% as compared to the nine months ended September 30, 2012. This is primarily due to the Company having two perfume licenses for the 2013 period compared to one license during the 2012 period.

 
29

 
 
Gross Profit. Our gross profit as a percentage of sales for the three months ended September 30, 2013 decreased 8.7% as compared to the three months ended September 30, 2012. This decrease is primarily due sales discounts issued to certain customers during the third quarter of 2013 that were not offered during the same period of 2012.  Our gross profit as a percentage of sales for the nine months ended September 30, 2013 increased 6% as compared to the nine months ended September 30, 2012. This increase is primarily related to the launch of Adam Levine during February 2013 and strong second quarter sales related to the launch.

In the three and nine months ended September 30, 2013, sales were substantially to department stores, perfumeries, specialty retailers, mass-market retailers, domestic and international wholesalers and distributors which resulted in higher gross margins, but were decreased as a result of product returns. In addition, our sales in the third quarter of 2013 included $135,998 of sales to related parties, while the third quarter of 2012 had $72,056 in related party sales. In 2013, we expect continued increases in our international sales, primarily in Canada and the United Kingdom, as well as increases in domestic sales resulting from new product launches for existing celebrities.

We have an agreement with a vendor to provide for order fulfillment, warehouse, logistic and administrative services for our fragrance products. In accordance with the agreement, the vendor is also entitled to fees, as defined, based on volume of customers’ orders processed, per unit costs, hourly rates incurred by this vendor. The agreement is one year with renewal options. In the event we do not renew our agreement and enter in new agreement with less favorable terms, our gross margins would decrease.

Costs relating to gift with purchase (GWP) promotions are reflected in Selling, General and Administrative expenses and aggregated $2,600 for the three months ended September 30, 2013 as compared to $118,700 for the three months ended September 30, 2012. Accordingly, our gross margin may not be comparable to other companies, which may include these expenses as a component of cost of sales. Had this amount been included in cost of sales, our gross margins would be reduced by .1% for the third quarter of 2013.  Costs relating to GWP for the nine months ended September 30, 2013 were $317,700 compared to $224,100 for the nine months ended September 30, 2012.  Period to period increases in GWP costs are due to the addition of our Adam Levine fragrance line in February 2013.

Selling, general and administrative expenses - During the second half of 2011, the Company entered the fragrance business, and began to sign licensing, manufacturing and distribution agreements for fragrance products relating to a celebrity artist that it had signed to a five year license. During 2012, the Company began to sell its products to department stores, perfumeries, specialty retailers, mass-market retailers, domestic and international wholesalers and distributors. Sales growth in 2012 was due in great part to the launch and rollout of the fragrance products relating to Selena Gomez. During February 2013, the Company launched the Adam Levine fragrance line.  The related Selling, General and Administrative expenses are discussed below for the three and nine months ended September 30:

   
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2013
   
2012
   
2013
   
2012
 
Professional fees
  $ 192,491     $ 147,918     $ 618,441     $ 595,952  
Royalties
    181,218       125,000       587,661       208,333  
Advertising and Promotion
    242,998       883,642       1,931,617       1,713,043  
Management fee
    -       43,450       -       375,117  
Payroll
    587,415       771,038       1,864,722       781,680  
Other
    453,348       213,639       1,486,871       435,638  
    $ 1,657,470     $ 2,184,687     $ 6,489,312     $ 4,109,763  

Professional fees – These expenses during 2012 and the first quarter of 2013 are primarily related to the Company hiring contractors/consultants and outside accountants and legal professionals to enable the Company to meet the filing requirements for the filing of Form 10. We have hired and are in the process of hiring internal accountants and expect our professional fees relating to contractors/consultants to decrease during the remainder of 2013, while we expect our payroll to increase to a lesser degree.  Additionally, the Company has incurred and expects to continue to incur additional legal fees throughout 2013 relating to our current litigation.

 
30

 
 
Royalties – Royalty expense includes the amortization and/or accrual of royalties pursuant to our fragrance licensing agreements. The Company is required to pay a minimum royalty, whether or not any product sales are made.  Royalty expense was $181,218 for the three months ended September 30, 2013 compared to $125,000 for the three months ended September 30, 2012.  The increase is due to the Adam Levine launch in February 2013 and related royalties for 2013 that did not exist in 2012.  Royalty expense was $587,661 for the nine months ended September 30, 2013 compared to $208,333 for the nine months ended September 30, 2012.  The increase was due to the Adam Levine launch in February 2013 and related royalties.

Advertising - The Company is required to spend minimum amounts for advertising based upon sales volume. These costs include promotional items, mailings, launch events, costs relating to gift with purchase promotions, department store models and domestic coop advertising expenses. Our annual advertising costs generally commence with each product launch. As a result, if our product launch occurs during the year, we would expect to incur more launch and advertising costs during the first few months following the product launch. The product launch for Adam Levine occurred in February 2013, and accordingly we had proportionately higher advertising costs following this launch. During the third quarter of 2013, the Company incurred $53,126 and $189,702 in advertising and promotion expenses for Selena Gomez and Adam Levine, respectively, for a total advertising and promotion expense of $242,998.  During the third quarter of 2012, the Company incurred $883,642 in advertising and promotion expenses for Selena Gomez. The decrease is due to the timing of product launches.  Substantial advertising and promotion costs are incurred for a product launch.  Selena Gomez launched May 2012 and there was no comparable launch during the second quarter of 2013. The Company is currently in compliance with minimum advertising requirements at September 30, 2013. With the September 9, 2013, termination of the Selena Gomez license, there will be no future advertising expenses related to the fragrance line.

Payroll - Payroll includes compensation for marketing, sales, administration and executive personal and increased as a result of the product launch in 2013. The Company has internalized many of the accounting related contractor/consultant expenses that are included in professional fees during 2012 and the first quarter of 2013, resulting in a decrease in Professional Fees expense and an increase in Payroll expense for the nine month periods ending September 30, 2013 and 2012.  The decrease in payroll expense for the three month periods ended September 30, 2013 and 2012 is due to a decreased head count from period to period.

Other - Included in other are three of our largest expenses, consisting of insurance, rent and manufacturer’s support fees. While we do not expect an increase in insurance expenses, there is no certainty that our insurance related expense will not significantly increase.  The Company does not anticipate any changes in the near future to our rent expense.  Freight and manufacturer’s support fees should increase or decrease proportionately with an increase or decrease in sales.

As we launch and roll out fragrances for new celebrities, our variable costs such as royalties, advertising and payroll are expected to increase.

Interest expense ­- Interest was incurred substantially to the Company’s chairman CEO principal shareholder and family members. Interest expense was $70,351 for the three months ended September 30, 2013 compared to $92,842 for the three months ended September 30, 2012. Interest expense decreased in comparing the third quarter of 2013 to the third quarter of 2012 due to decrease in factored receivables from period to period and a decrease in related interest expense.
 
Net income (loss) from continuing operations - As a result of the factors described above, the Company reported a net loss from continuing operations of $1,025,326 in the third quarter of 2013 compared to net loss of $1,121,406 in the third quarter of 2012. The net loss from continuing operations is comparable from period to period as the Company experienced a decrease in sales from one perfume license that was offset by an increase in sales from another license. The Company reported net loss from continuing operations of $3,729,197 for the nine months ended September 30, 2013 compared to net loss of $2,577,120 for the nine months ended September 30, 2012.  The increase in net loss from period to period is due to the Adam Levine fragrance line launch in February 2013 and the related costs to launch, including large advertising and promotion costs incurred around the launch date.

Discontinued Operations - Through September 30, 2011, the Company primarily owned and operated retail stores in several states which sold active beach and rugged sportswear. The Company began closing stores at unprofitable locations in 2009 and continued to do so through 2011. In this connection, on September 30, 2011, the Company formally decided to discontinue its retail store operations that sold active sportswear, and to close, abandon, dispose or sell its assets relating to its retail operations. The Company decided to dispose of its retail stores because it incurred significant operating losses and was unable to sustain a viable business model for the past six years.

Retail sales, reported in discontinued operations, aggregated $37,409 and $106,207 for the three and nine months ended September 30, 2012. Net loss, reported in discontinued operations, aggregated $63,147 and $444,255, including gain on disposal – related party of $63,223, for the three and nine months ended September 30, 2012. This is attributable to the Company completing the disposition of its retail business during 2012.  The Company has not incurred and does not anticipate any additional discontinued operations amounts during 2013.

Two stores were disposed of in 2011 and the leases were terminated by the landlord. Management, based on the opinion of counsel, believe that the Company is not obligated for any lease payments beyond the termination dates, nor obligated to return the lease incentives or lease concessions previously given to the Company in prior years, which aggregated $12.6 million at December 31, 2012. In the event the Company would have to pay such amount, the payment would have a material impact on the Company’s liquidity, capital resources and results of operations.

Earnings per share - We compute basic and diluted loss per common share by dividing the losses applicable to common stock by the weighted average number of common shares outstanding. Currently, our basic and fully diluted EPS calculations are the same for the three and nine month periods ended September 30, 2013 and 2012, because any increase in the number of dilutive shares would be anti-dilutive due to our net loss.
 
 
31

 
 
Liquidity and Capital Resources

Our auditors have issued a going concern opinion on our audited financial statements for the year ended December 31, 2012 as we have experienced recurring losses and negative cash flows from operations.  In addition, we have a net capital deficiency.  These matters raise substantial doubt about our ability to continue as a going concern.
 
We had a working capital deficiency of $11.1 million as of September 30, 2013 and December 31, 2012. As a result of our second brand licensing agreement, the Company anticipates it will require approximately $1.5 million to $2.1 million of sales per month to maintain its operations.

Our principal funding requirements are for inventory purchases, advertising expenses, paying down accounts payable and debt. These capital requirements generally have been satisfied through cash flows from operations, the issuance of common stock and notes payable to affiliates and related parties. Our liquidity is impacted by a number of factors, including sales levels, timing of accounts receivable collections, the amount of credit that our vendors extend to us, customer deposits and our borrowing capacity from Company’s chairman CEO principal shareholder and family members and affiliated companies owned and/or controlled by our Company’s chairman CEO and principal shareholder. As of September 30, 2013, our loan payable totaled $1,363,076 and our related party and stockholder notes payable totaled $2,750,338 with interest rates from zero to 12%. The terms of repayment of these loans ranged from due on demand to 2.25 years. During September 2013, the Company renegotiated payments terms of certain debts with $2,650,408 being classified as long-term with due dates of December 31, 2015. See note 6 “Loan payable and stockholder notes” and note 7 “Note payable related party” for further discussion. Due to affiliate of $100,919 at September 30, 2013 has no terms of repayment and is shown as current. Our accounts receivable were $178,982 at September 30, 2013. Our customers are generally given terms of payment within 30 days.
 
Cash used in operating activities of ($2,237,294) primarily represents income (loss) before depreciation and non-cash charges and is after changes in working capital. Cash provided by (used in) operating activities were due to changes in accounts receivable ($179,000), inventory ($1.7 million), accounts payable $2.7 million, accrued liabilities $327,000, and customer deposits ($256,000). Working capital is significantly impacted by changes in accounts receivable, inventory, accounts payable and accrued liabilities and customer deposits. The Company’s shortage of cash results in increases in accounts payable and accrued liabilities resulting from the Company’s ability to extend its vendor terms to provide a significant portion of our liquidity. The Company’s cash position was negatively impacted by customer deposits. The increase in our inventory is needed to support our expected sales growth primarily resulting from our licensing activities. All sales are invoiced in U.S dollars and all customer payments are received in U.S. dollars. The Company does not engage in hedging transactions and believes that it is not subject to foreign currency related risks.
 
Net cash used in investing activities of ($66,000), represents the purchases of molds which are used for product development, less molds disposed of related to the Selena Gomez settlement. These purchases vary based on the number of new products we are developing each year. Our business is not capital intensive as we do own any manufacturing facilities and as such we have no material commitments for capital expenditures.
 
Net cash provided by financing activities was $2.0 million. Such increase in cash reflects the excess of net borrowings from related parties and stockholders of $136,000, proceeds from the issuance of convertible debenture of $500,000, borrowings from a related company of $560,000, net borrowings from notes payable of $233,000, net borrowings from short term borrowings – related party of $549,000 and proceeds from the issuance of common stock of $60,000 over repayment of advances from affiliated company of $48,000. We have no available short-term lines of credit or any long term borrowing arrangements with any financial institution and as such we are dependent of related party borrowings, the issuance of stock, and other financial debt sources to provide cash for our financing activities.

Our cash position was $3,500 and $316,000 at September 30, 2013 and December 31, 2012, respectively.
 
 
32

 
 
Plan of Operation

We were not able to generate any significant cash flow to fund our current operations. However, we believe that our current business model will sustain us for the next twelve months. Currently, we are seeking additional outside funding to keep the business operational; however there is no assurance additional debt or capital will be available to us on acceptable terms. We believe our entrance into the perfume business in the third quarter of 2011, and entering into distribution agreements will establish viable distribution channels for our fragrance products. Management believes that the actions taken may provide an opportunity to improve liquidity and profitability. However, if we were to expand operations through acquisitions, new licensing arrangements or both, we may need to obtain additional debt or equity financing. 

Further, we are implementing a cash conservation strategy wherever possible including active COO involvement in substantially all contracts and purchase decisions, negotiating payment terms with vendors, and reducing our use of consulting services. For instance, we replaced a contract manufacturer/distributer with one that provides more favorable payment terms. However, our ability to continue to effectively improve our terms with vendors, raise cash through equity or debt financing with third parties will be difficult in the current credit environment. There are no assurances that any equity offering and/or debt financing will be successful or sufficient to meet our cash requirements or that our cash conservation strategy will be successful. Even if we were able to obtain debt or equity financing, the terms of such financing may be very unfavorable to us. Further, any sale of newly issued debt or equity securities could result in additional dilution to our current stockholders.

Dividends
 
Holders of common stock are entitled to receive such dividends as the board of directors may from time to time declare out of funds legally available for the payment of dividends. No cash dividends have been paid on our common stock, and we do not anticipate paying any cash dividends on our common stock in the foreseeable future.
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.  All invoices are denominated in U.S. dollars.

ITEM 4. CONTROLS AND PROCEDURES

(a)
Evaluation of Disclosure Controls and Procedures
 
Our management, with the participation of our Chief Executive Officer and our Chief Operating Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q. The evaluation considered the procedures designed to ensure that the information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and communicated to our management as appropriate to allow timely decisions regarding required disclosure.
 
(b)
Changes in Internal Control over Financial Reporting
 
During the period covered by this Quarterly Report on Form 10-Q, there was no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(d) and 13d-15(d) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
(c)
Inherent Limitations of Disclosure Controls and Internal Controls over Financial Reporting
 
Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation or effectiveness to future periods are subject to risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
 
33

 
 
PART II OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
On March 11, 2013 Victory International (USA) LLC (“Victory”) filed a lawsuit against ID Perfumes.  The lawsuit was filed in the United States District Court, District of New Jersey (Civil Action No. cv-01465-FSH-PS).  The lawsuit seeks damages in excess of $1.2 million as well as injunctive relief.  We have filed affirmative defenses and a counterclaim against Victory for breach of contract. We are seeking compensatory, consequential and economic damages in excess of $45 million.  (See Company’s Form 10-Q filed August 14, 2013 and on May 20, 2013 for additional information.)

As reported in the Company’s Form 8-k filed September 17, 2013 we have settled the lawsuit which we filed against Selena Gomez and July Moon Productions.  With the execution of the Settlement Agreement and Mutual Release, the Licensing Agreement with Selena Gomez has been terminated.

ITEM 1A. RISK FACTORS

Except as set forth below, there have been no material changes in our risk factors since the filing of Amendment Number Four to our Form 10 filed August 5, 2013.

Unauthorized disclosure of sensitive or confidential customer information could harm the Company’s business and standing with our customers.

The protection of our customer, employee and Company data is critical to us. The Company relies on commercially available systems, software, tools and monitoring to provide security for processing, transmission and storage of confidential customer information, such as payment card and personal information. Despite the security measures the Company has in place, its facilities and systems, and those of its third party service provider, may be vulnerable to security breaches, acts of vandalism, computer viruses, misplaced or lost data, programming and/or human errors, or other similar events. Any security breach involving the misappropriation, loss or other unauthorized disclosure of confidential information, whether by the Company or its vendors, could damage our reputation, expose us to risk of litigation and liability, disrupt our operations and harm our business.

We may be subject to claims and our insurance may not be sufficient to cover damages related to those claims.

We may be subject to lawsuits resulting from injuries associated with the use of our fragrances. In addition, we may also be subject to lawsuits relating to the design, manufacture or distribution of our private label products. Additionally, we may incur losses relating to these claims or the defense of these claims and there is a risk that claims or liabilities will exceed our insurance coverage and we may be unable to retain adequate liability insurance in the future.

We have defaulted on loan obligations.

We have incurred loans totaling approximately $1.4 million from third parties of which approximately $230,000 is in default. In addition, we have incurred loans totaling approximately $3.3 million from related parties of which approximately $99,930 is in default. The amount in default is from a former executive of Adrenalina, Inc. in 2007 and there has been no demand for payment. The Company does not expect an adverse effect on operations as a result of these defaults. However, should these creditors choose to foreclose on these loans, our ongoing business operations may be impaired.
 
 
34

 
 
ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
On August 12, 2013, the Company issued to Commonwealth Wholesale Corporation a common stock purchase warrant to purchase up to 500,000 shares of common stock with an exercise price of $4.00 per share. The warrants are exercisable immediately and expire August 31, 2018.

At all times relevant:

- the  sale  was  made  to  a  sophisticated  or  accredited  investor;

-  we gave the purchaser the opportunity to ask questions and receive answers concerning  the terms and conditions of the offering and to obtain any additional information which we possessed or could acquire without unreasonable effort or expense that is necessary to verify the accuracy of information furnished;

- at a reasonable time prior to the sale of securities, we advised the purchaser of  the  limitations on resale of the securities; and

- neither we nor any person acting on our behalf sold the securities by any form of general solicitation or general advertising.

In issuing the foregoing securities, we relied on the exemptive provisions of Section 4(2) of the Securities Act.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES
 
None.

ITEM 4. MINE SAFETY DISCLOSURES
 
Not applicable.
 
ITEM 5. OTHER INFORMATION
 
None.

ITEM 6. EXHIBITS

Index to Exhibits

4.4*
Gigantic Parfums Promissory Note with Parfums Investment, LLC.
4.5
Amendment to Non-Negotiable Promissory Note, Security Agreement and Assignment and Pledge between Gigantic Parfums, LLC and Parfums Investment,  LLC and Interest Rate Amendment
31.1
Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
31.2
Certifications of the Treasurer pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
32.1
Certifications of President pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
Certifications of Treasurer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*  
Previously filed with the Company’s Registration Statement on Form 10 filed  with the Securities and Exchange Commission on April 30, 2013

 
35

 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on November 18, 2013 on its behalf by the undersigned, thereunto duly authorized.
 
 
ID Perfumes
 
       
 
By:
/s/ Ilia Lekach
 
   
Ilia Lekach
 
   
Chief Executive Officer
 
       
 
By:
/s/ Ilia Lekach
 
   
Ilia Lekach
 
   
Chief Financial Officer
 
 
 
36